Quick Answer
Kura Oncology, Inc. reported Total Assets of $738.36 million for fiscal year 2025.
Kura Oncology, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $738.36M | -2.9% |
| 2024 | $760.16M | +69.3% |
| 2023 | $448.94M | -1.6% |
| 2022 | $456.31M | -14.6% |
| 2021 | $534.05M | -17.5% |
| 2020 | $647.21M | +167.5% |
| 2019 | $241.97M | +32.7% |
| 2018 | $182.38M | +90.3% |
| 2017 | $95.85M | +37.3% |
| 2016 | $69.82M | -20.0% |
| 2015 | $87.26M | +6232.3% |
| 2014 | $1.38M | +15096.3% |
| 2013 | $9.1K | +9.2% |
| 2012 | $8.3K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $649.38M | +35.6% | -4.8% |
| June 30, 2025 | $682.42M | +32.5% | -8.2% |
| March 31, 2025 | $743.76M | +34.3% | -2.2% |
| December 31, 2024 | $760.16M | +69.3% | +58.8% |
| September 30, 2024 | $478.84M | +1.1% | -7.0% |
| June 30, 2024 | $515.12M | +4.1% | -7.0% |
| March 31, 2024 | $553.91M | +30.0% | +23.4% |
| December 31, 2023 | $448.94M | -1.6% | -5.2% |
- Kura Oncology, Inc. showed a decrease of -2.9% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Kura Oncology, Inc.’s total assets has grown by 8893696.7% (from $8.3 thousand to $738.36 million).
- The most recent figure is from Kura Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: